title: Deal watch: Abbott boosts investment in NRF2 activators for reducing oxidative stress.
authors.forename: Sarah
authors.initials: S
authors.lastname: Crunkhorn
mesh_terms: D000975:Antioxidants / Q000627:therapeutic use*; D004345:Drug Industry; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D051267:NF-E2-Related Factor 2 / Q000819:agonists*; D009828:Oleanolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D018384:Oxidative Stress / Q000187:drug effects*
chemical_list: D000975:Antioxidants; D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human; D009828:Oleanolic Acid; C445068:bardoxolone methyl